+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative activity of two newer cephalosporins, cefoxitin, and cephalothin against selected Enterobacteriaceae and correlation with enzymatic resistance mechanisms



Comparative activity of two newer cephalosporins, cefoxitin, and cephalothin against selected Enterobacteriaceae and correlation with enzymatic resistance mechanisms



Journal of Antimicrobial ChemoTherapy 5(3): 293-300




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 039614511

Download citation: RISBibTeXText

PMID: 314440

DOI: 10.1093/jac/5.3.293


Related references

Activity of cefoxitin cefuroxime cefamandole and cephalothin against 200 enterobacteriaceae. Clinical Therapeutics 2(6): 382-386, 1980

In vitro susceptibility of cephalothin-resistant enterobacteriaceae andPseudomonas aeruginosato a one-oxa cephalosporin (LY 127935 or moxalactam), amikacin, and selected cephalosporins. Current Microbiology 3(5): 301-304, 1980

In vitro activity of cefotaxime against enterobacteriaceae. Comparison with cephalothin, cefazolin, cefamandole, cefoxitin and cefuroxime on 117 strains isolated from neutropenic patients. La Nouvelle Presse Medicale 10(8): 545-547, 1981

Comparative staphylolytic activity of cefoxitin, cephalothin and cefuroxime. Journal of Antimicrobial ChemoTherapy 6(4): 511-517, 1980

Enhanced in vitro bactericidal activity of amikacin or gentamicin combined with 3 new extended spectrum cephalosporins against cephalothin resistant members of the family enterobacteriaceae. Antimicrobial Agents and Chemotherapy 25(6): 725-728, 1984

Enhanced in vitro bactericidal activity of amikacin or gentamicin combined with three new extended-spectrum cephalosporins against cephalothin-resistant members of the family Enterobacteriaceae. Antimicrobial Agents and ChemoTherapy 25(6): 725-728, 1984

Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin. Scandinavian Journal of Infectious Diseases. Supplementum: 88-93, 1978

In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786. Journal of Antibiotics 30(4): 326-329, 1977

Prevalence and in vitro sensitivity of Enterobacteriaceae to cefoxitin and new cephalosporins. Acta Clinica Belgica 34(4): 202-207, 1979

Antibacterial activity of selected beta-lactam and aminoglycoside antibiotics against cephalothin-resistant Enterobacteriaceae. Antimicrobial Agents and ChemoTherapy 9(5): 780-786, 1976

Comparison of the antimicrobial activity and beta-lactamase resistance of cef otiam (CGP/14221 E) with that of cefotaxime, cefuroxime, cefoxitin and cephalothin. Current Medical Research and Opinion 7(10): 639-648, 1982

Genetic analysis of porin-dependent mechanisms causing increased resistance to cefoxitin and third-generation cephalosporins in Klebsiella pneumoniae. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 36: 41, 1996

Molecular mechanisms of cephalosporins resistance in gramnegative bacteria of the enterobacteriaceae family. Antibiotiki i Khimioterapiya 49(3): 6-16, 2004

Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks. Journal of Infectious Diseases 137 Suppl: S32, 1978

Comparative in vitro activity of newer cephalosporins. Saudi Medical Journal 15(3): 212-218, 1994